Cl.[F:2][C:3]([F:33])([F:32])[C:4]1[CH:5]=[C:6]([CH:25]=[C:26]([C:28]([F:31])([F:30])[F:29])[CH:27]=1)[CH2:7][N:8]([CH2:21][CH2:22][CH2:23][NH2:24])[C:9]([C:11]1[C:12]([Cl:20])=[N:13][C:14]([S:18][CH3:19])=[N:15][C:16]=1Cl)=[O:10].C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O.C(OCC)(=O)C>[F:30][C:28]([F:31])([F:29])[C:26]1[CH:25]=[C:6]([CH:5]=[C:4]([C:3]([F:33])([F:2])[F:32])[CH:27]=1)[CH2:7][N:8]1[CH2:21][CH2:22][CH2:23][NH:24][C:16]2[N:15]=[C:14]([S:18][CH3:19])[N:13]=[C:12]([Cl:20])[C:11]=2[C:9]1=[O:10]N-[3,5-bis(trifluoromethyl)benzyl]-N-(3-aminopropyl)-4,6-dichloro-2-(methylthio)pyrimidine-5-carboxylic acid amide hydrochloride (Compound of Reference Example 6; 3.35 g) was dissolved in N,N-dimethylformamide (6 mL). To this solution, potassium carbonate (4.15 g) was added and the mixture was stirred at 100° C. for 1 hour. The reaction mixture was diluted with ethyl acetate, was sequentially washed with water and a saturated aqueous solution of sodium chloride, and was then dried over anhydrous sodium sulfate. Following removal of the solvent, the residue was purified on a silica gel column chromatography (ethyl acetate:hexane=1:1) to obtain 6-[3,5-bis(trifluoromethyl)benzyl]-4-chloro-5,6,7,8,9,10-hexahydro-2-(methylthio)-5-oxopyrimido[4,5-b][1,5]diazocine (2.05 g, 70%).